As of 2025-03-17, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is -29.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 423.38 mil USD. HCAT's TTM EBITDA according to its financial statements is -14.28 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 13.4x | 12.0x |
| Forward P/E multiples | 10.8x - 19.4x | 16.3x |
| Fair Price | (4.09) - (4.61) | (4.77) |
| Upside | -198.8% - -211.3% | -215.3% |
| Date | EV/EBITDA |
| 2025-03-12 | -31.07 |
| 2025-03-11 | -29.79 |
| 2025-03-10 | -28.81 |
| 2025-03-07 | -30.38 |
| 2025-03-06 | -31.07 |
| 2025-03-05 | -31.66 |
| 2025-03-04 | -31.51 |
| 2025-03-03 | -31.91 |
| 2025-02-28 | -32.25 |
| 2025-02-27 | -30.87 |
| 2025-02-26 | -33.58 |
| 2025-02-25 | -33.63 |
| 2025-02-24 | -33.92 |
| 2025-02-21 | -35.00 |
| 2025-02-20 | -35.79 |
| 2025-02-19 | -36.58 |
| 2025-02-18 | -35.84 |
| 2025-02-14 | -35.94 |
| 2025-02-13 | -36.58 |
| 2025-02-12 | -36.04 |
| 2025-02-11 | -36.33 |
| 2025-02-10 | -37.56 |
| 2025-02-07 | -37.31 |
| 2025-02-06 | -36.28 |
| 2025-02-05 | -38.25 |
| 2025-02-04 | -36.92 |
| 2025-02-03 | -36.18 |
| 2025-01-31 | -36.97 |
| 2025-01-30 | -36.43 |
| 2025-01-29 | -36.97 |
| 2025-01-28 | -37.81 |
| 2025-01-27 | -37.22 |
| 2025-01-24 | -37.66 |
| 2025-01-23 | -37.76 |
| 2025-01-22 | -36.87 |
| 2025-01-21 | -37.22 |
| 2025-01-17 | -36.28 |
| 2025-01-16 | -36.33 |
| 2025-01-15 | -37.61 |
| 2025-01-14 | -38.30 |
| 2025-01-13 | -41.20 |
| 2025-01-10 | -43.16 |
| 2025-01-08 | -45.47 |
| 2025-01-07 | -43.61 |
| 2025-01-06 | -45.67 |
| 2025-01-03 | -45.77 |
| 2025-01-02 | -45.35 |
| 2024-12-31 | -44.05 |
| 2024-12-30 | -43.75 |
| 2024-12-27 | -44.10 |